DXC Technology Co (DXC)vsZepp Health Corp (ZEPP)
DXC
DXC Technology Co
$11.47
-3.29%
TECHNOLOGY · Cap: $2.02B
ZEPP
Zepp Health Corp
$18.01
+2.56%
TECHNOLOGY · Cap: $270.28M
Smart Verdict
WallStSmart Research — data-driven comparison
DXC Technology Co generates 4799% more annual revenue ($12.68B vs $258.90M). DXC leads profitability with a 3.3% profit margin vs -15.5%. DXC earns a higher WallStSmart Score of 67/100 (B-).
DXC
Strong Buy67
out of 100
Grade: B-
ZEPP
Hold38
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+89.2%
Fair Value
$127.79
Current Price
$11.47
$116.32 discount
Margin of Safety
+48.9%
Fair Value
$46.96
Current Price
$18.01
$28.95 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
Attractively priced relative to earnings
Reasonable price relative to book value
Earnings expanding 96.8% YoY
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
3.3% margin — thin
Elevated debt levels
Revenue declined 1.0%
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : DXC
The strongest argument for DXC centers on PEG Ratio, P/E Ratio, Price/Book. PEG of 0.49 suggests the stock is reasonably priced for its growth.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : DXC
The primary concerns for DXC are Profit Margin, Debt/Equity, Revenue Growth. Debt-to-equity of 1.52 is elevated, increasing financial risk. Thin 3.3% margins leave little buffer for downturns.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
DXC profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
DXC generates stronger free cash flow (372M), providing more financial flexibility.
Bottom Line
DXC scores higher overall (67/100 vs 38/100). ZEPP offers better value entry with a 48.9% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DXC Technology Co
TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA
DXC Technology is an American multinational corporation that provides business-to-business information technology services.
Visit Website →Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other INFORMATION TECHNOLOGY SERVICES Stocks
Want to dig deeper into these stocks?